Health
COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark – BioSpace
Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.
Patients in a Phase II trial have begun receiving Modernas vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced. The modified vaccine, mRNA-1273.351, is being tested out of an abundance of caution, despite the fact that previous data has shown that the companys marketed mRNA-1273 vaccine produces neutralizing titers against all relevant variations, the company said.
Similarly inspired by caution, Denmark announced it is temporarilystopping vaccinations with…
-
General15 hours agoPublisher ditches David Walliams after harassment claim
-
General13 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General12 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
Business9 hours agoThe ETF portfolio I’d build if I never wanted to watch markets again